91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
In the ever-expanding universe of real world data, exploration and visualization strategies have become indispensable. This article presents
-
91黑料's Richard Pitman and Pragya Khurana provide insights on the that demonstrate the value that vaccines bring to healthcare systems.
-
91黑料 experts Michele Bennett, Ewa J. Kleczyk, Karin Hayes and Rajesh Mehta explain why .
-
Kathleen Mandziuk, VP of Real-World Solutions, offers her insights on .
-
Kathleen Mandziuk, VP Real World Solutions, offers insights into .
-
William Maier, VP Rare Diseases, Drug Development Sciences, considers .
-
Veronica Gutierrez Martinez and Michael Tokar discuss .
-
AI in Life Sciences – Covid pushes AI driven clinical trials and drug manufacturing into the limelight
91黑料’s CIO, Tom Leary discusses the challenges to patient recruitment during the COVID pandemic and how big data, combined with advanced AI algorithms processing has the potential to reduce trial costs.
-
Managed access programmes (MAPs) are often unfamiliar territory for clinical teams, as their purpose and regulatory environment are very different from randomised controlled trials. 91黑料's Veronica Gutierrez Martinez considers how .
-
With in-person scientific congresses an impossibility for the foreseeable future, researchers and publishers have to adapt how they foster scientific exchange.
